[The diagnostic value of pharmacoangiography in tumourous and inflammatory diseases of bones and soft tissues (author's transl)].
The value of pharmaco-angiography (Priscol, angiotensin) in the diagnosis of tumourous and inflammatory diseases in bones and soft tissues was investigated in 81 patients. Priscol was used in 49 patients, angiotensin in 28 and both substances in four. It was shown that neither Priscol nor angiotensin produced results of diagnostic value, provided an optimal technique was used (antegrade, selective contrast injection with an adequate volume of contrast and in the absence of vascular spasm). Priscol was of value for reducing or preventing spasm in peripheral vessels. Angiotensin is superior to Priscol in demonstrating the angiographic criteria, but pharmaco-angiography did not result in a better distinction between tumours and inflammatory lesions.
D000293:Adolescent; D000328:Adult; D000792:Angiography; D000804:Angiotensin II; D001859:Bone Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010000:Osteitis / Q000000981:diagnostic imaging*; D012983:Soft Tissue Neoplasms / Q000000981:diagnostic imaging*; D014043:Tolazoline
D000804:Angiotensin II; D014043:Tolazoline
Diagnostischer Wert der Pharmakoangiographie bei tumorösen und entzündlichen Knochen- und Weichteilprozessen. Ein Bericht über 81 Fälle.